HMG CoA Reductase Inhibitors and Impotence: Two Case Series from the Spanish and French Drug Monitoring Systems

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.2, 2006-01, pp. : 143-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG CoA reductase inhibitors: Cholecystitis (first report for simvastatin): case report

Reactions Weekly, Vol. 1, Iss. 1126, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Who Should Receive HMG CoA Reductase Inhibitors?

By Teo K.K.

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1707-1715

Adis International

Access to resources Recommend Favorite

In his comment regarding HMG CoA reductase inhibitors [statins] for stroke prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors

By Williams D. Feely J.

Clinical Pharmacokinetics, Vol. 41, Iss. 5, 2002-01 ,pp. : 343-370

Adis International

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors/paracetamol: Liver failure: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite